Merck Serono appoints Meeta Gulyani as Head of Strategy and Global Franchises


Meeta Gulyani

Merck Serono has appointed Meeta Gulyani to the position of head of strategy and Global Franchises as of May 7, 2014. Gulyani will be based in Boston, US and will report to Belén Garijo, President and Chief Executive Officer, Merck Serono.

Gulyani will be leading Merck Serono’s global franchises (multiple sclerosis and immunology, oncology, fertility, general medicine and endocrinology, and medical devices), with a strong focus on defining integrated strategies for the different disease areas, ensuring rigorous allocation of resources in line with the strategy, as well supporting drive Merck Serono’s operating performance through marketing excellence.

“I am pleased to have Meeta on board as we are moving into a new phase of Merck Serono’s transformation, focused on growth, and seek to maximise the value of our current product portfolio and build our future product offering,” said Garijo.

Gulyani joins Merck Serono from Roche where she was most recently general manager for South Asia, covering India, Sri Lanka, Bangladesh and Nepal, and previously Vice President of Global Portfolio Management. Prior to joining Roche in 2010, Gulyani spent eight years at Sanofi. She holds an MBA from the Asian Institute of Management, Philippines, accompanied by an exchange programme at Wharton, University of Pennsylvania, US, and a BA in Economics from the Shri Ram College of Commerce from the Delhi University, India.

EP News BureauMumbai

Comments (0)
Add Comment